AMSTERDAM, April 20, 2016 /PRNewswire/ -- As part of the
company's focus on the development of advanced monitoring
solutions, Royal Philips (NYSE: PHG;
AEX: PHIA) today announced the launch of its IntelliVue patient
monitoring platform with Masimo rainbow® SET technology.
Philips also offers its customers the option to add
rainbow® SET to existing IntelliVue monitors, and the
company is working to integrate the technology into its Philips
SureSigns and Philips Efficia patient monitoring platforms.
In conjunction with the appropriate Philips patient monitoring
platform, Masimo rainbow® SET technology analyzes
multiple wavelengths of light to accurately measure total
hemoglobin (SpHb™), oxygen content (SpOC®),
carboxyhemoglobin (SpCO™), methemoglobin
(SpMet®) and Pleth Variability Index (PVI®)
noninvasively and continuously. Continuous monitoring of rainbow
SpHb™ on a Philips monitor at the point-of-care provides
clinicians with real-time visibility to changes in hemoglobin in
between invasive blood sampling.
To ensure that customers have choice of SpO2 pulse oximetry
measurement technology, Philips continues to offer Philips FAST
SpO2 pulse oximetry and Covidien's OxiMax SpO2 pulse oximetry,
depending on the patient monitoring platform.
Philips offers a comprehensive portfolio of patient monitoring
solutions ranging from bedside monitors to wearable patient
monitors, combined with clinical decision support tools and mobile
applications to provide immediate access to centrally held patient
data. More than 275 million patients were monitored with Philips'
patient monitors in 2014.
For further information, please contact:
Steve Klink
Philips Group Communications
Tel.: +31 6 10888824
E-mail: steve.klink@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX:
PHIA) is a leading health technology company focused on improving
people's health and enabling better outcomes across
the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to
deliver integrated solutions. The company is a leader in
diagnostic imaging, image-guided therapy, patient monitoring
and health informatics, as well as
in consumer health and home care. Philips'
wholly owned subsidiary Philips Lighting is the
global leader in lighting products, systems and
services. Headquartered in the
Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately
104,000 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-expands-patient-monitoring-portfolio-with-additional-measurement-technologies-300254405.html
SOURCE Royal Philips